Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Exor N.V. trades at a 55% discount to audited NAV, offering exposure to high-quality holdings like Ferrari, Philips, and Institut Mérieux. EXOR's NAV per share has compounded at 16% annually since 2009, materially outperforming global indices, driven by disciplined capital allocation and anchor holdings. Portfolio simplification, ongoing buybacks, and investment-entity reporting are expected to drive mid-teens NAV growth and gradual discount narrowing over the next decade.

Exor N.V. (EXXRF) trades at an unusually wide ~60% discount to NAV, offering exposure to Ferrari and other assets at a compelling valuation. Ferrari's resilient demand, pricing power, and disciplined production underpin its value, despite recent EV-related volatility and a still-high ~38x earnings multiple. Lingotto, Exor's asset management arm, has tripled AUM to €10B since 2023, with strong returns from concentrated positions in outperformers like Teva and Carvana.

Philips' largest shareholder Exor , the investment arm of Italy's Agnelli family, has ​extended its agreement with the health ‌technology firm, giving it the flexibility to increase its stake to up to 22%, the ​companies said on Tuesday.